JATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering
View original at globenewswire.comJATT II Acquisition Corp Announces Pricing of $60,000,000 Initial Public Offering WESTFIELD, N.J., April 16, 2026 (GLOBE NEWSWIRE) -- JATT II Acquisition Corp (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial pu…
What we drew from this source
The claims Via News extracted from this document. We point to the source; we don't replace it.
The Company intends to focus its search on healthcare and healthcare-related businesses, with a primary emphasis on biotechnology and broader life sciences
60% confidenceThe Company has not selected any specific business combination target and has not engaged in any substantive discussions with any business combination target
60% confidenceThe Company expects to focus particularly, though not exclusively, on businesses applying data-driven approaches, including machine learning, computational biology, structure-based drug design and related technologies, to improve the therapeutic discovery and development process
60% confidenceThe Company intends to seek businesses that can benefit from the clinical, scientific, operational, strategic and capital markets experience of the management team and board of directors
60% confidence